The Maryland company, which has a $1.75 billion federal contract to develop and produce a coronavirus vaccine, said it needed to address the concerns of federal regulators.The Maryland company, which has a $1.75 billion federal contract to develop and produce a coronavirus vaccine, said it needed to address the concerns of federal regulators.Novavax Inc, Vaccination and Immunization, Coronavirus (2019-nCoV), Factories and Manufacturing, United States Politics and Government, Health and Human Services Department, Food and Drug AdministrationRead More
